Rheumatoid heart disease with rheumatoid arthritis of unspecified site
ICD-10 M05.30 is a billable code used to indicate a diagnosis of rheumatoid heart disease with rheumatoid arthritis of unspecified site.
Rheumatoid heart disease is a complication of rheumatoid arthritis (RA), an autoimmune disorder characterized by chronic inflammation of the joints. The pathophysiology involves the deposition of immune complexes in the heart, leading to inflammation of the pericardium (pericarditis), myocardium (myocarditis), or endocardium (endocarditis). Clinically, patients may present with symptoms such as chest pain, dyspnea, and fatigue, alongside the typical manifestations of RA, including joint swelling, stiffness, and deformities. Anatomically, the heart consists of four chambers (two atria and two ventricles) and is surrounded by the pericardium. In RA, the inflammatory process can affect the heart valves and the conduction system, potentially leading to arrhythmias or heart failure. The presence of rheumatoid heart disease indicates a more severe systemic involvement of RA, necessitating comprehensive management strategies that address both joint and cardiac health.
Orthopedic documentation should include imaging studies (X-rays, MRIs) to assess joint damage, functional assessments, and treatment plans addressing joint involvement.
Patients may require joint surgeries (e.g., arthroplasty) due to severe RA-related deformities.
Documentation must specify the joints involved and the severity of damage to guide treatment decisions.
Rheumatologic documentation should include laboratory tests (e.g., rheumatoid factor, anti-CCP antibodies), inflammation markers (ESR, CRP), and assessments of disease activity (DAS28).
Management of RA flares and systemic manifestations, including cardiovascular assessments.
Systemic involvement must be documented, including any cardiac symptoms and their impact on overall health.
Functional assessments should evaluate mobility limitations, pain levels, and the need for assistive devices.
Rehabilitation programs focusing on improving joint function and cardiovascular health.
Mobility limitations due to both joint and cardiac issues must be documented to justify therapy.
Used to assess cardiac function in patients with RA.
Document indications for ECG and any findings related to RA.
Cardiology and rheumatology collaboration is essential.
Common symptoms include chest pain, shortness of breath, fatigue, and palpitations, often alongside joint pain and swelling typical of rheumatoid arthritis.